USPTO serial 50006748
DUALTA
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- ORSCHELN, COLLEEN J
- Law office
- TMO LAW OFFICE 132
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DUALTA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Makiko Coffland
Makiko Coffland Christensen O'Connor Johnson Kindness1201 Third Avenue, Suite 3600Seattle, WA 98101United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical additives for use in the manufacture of pharmaceuticals; Active chemical ingredients for use in the manufacture of pharmaceuticals; Biological preparations for use in industry and science | ACTIVE | — |
| 003 | Cosmetic preparations; Cosmetics sold as an integral component of non-medicated skincare preparations | ACTIVE | — |
| 005 | Pharmaceutical preparations for the treatment and prevention of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty related diseases or disorders, gynecological disorders, fertility, acromegaly and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, hematological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases and disorders, muscle disorders, bone disorders, skeletal disorders, peripheral nervous system disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain; Pharmaceutical preparations for the treatment and prevention of glabellar lines, forehead lines, lateral canthal lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Diagnostic substances for medical use | ACTIVE | — |
| 010 | Medical apparatus for use in treating cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty related diseases or disorders, gynecological disorders, fertility, acromegaly and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, hematological diseases and disorders; Medical apparatus for use in treating gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases and disorders, muscle disorders, bone disorders, skeletal disorders, peripheral nervous system disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain, glabellar lines, forehead lines, lateral canthal lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical devices for use in treating or diagnosing cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty related diseases or disorders, gynecological disorders, fertility, acromegaly and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, hematological diseases and disorders; Medical devices for use in treating or diagnosing gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases and disorders, muscle disorders, bone disorders, skeletal disorders, peripheral nervous system disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain, glabellar lines, forehead lines, lateral canthal lines, facial wrinkles, asymmetries and defects and conditions of the human skin | ACTIVE | — |
| 041 | Providing information about education; Arranging and conducting of seminars and workshops in the field of science, health, medicine, pharmacy and beauty; Publishing e-books in the field of science, health, medicine, pharmacy and beauty; Providing online non-downloadable journals in the field of science, health, medicine, pharmacy and beauty; Publishing and issuing scientific papers in relation to medical technology; Instruction in the field of cosmetology | ACTIVE | — |
| 044 | Pharmaceutical advice; Pharmaceutical compounding services; Dispensing of pharmaceuticals; Medical services; Healthcare; Providing healthcare information; Providing educational information about healthcare; Internet-based health care information services; Providing medical information; Medical and pharmaceutical consultation; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing news and information in the field of medicine | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ipsen Biopharm Limited
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 041
- Other trademarks in Class 044
- Similar marks named DUALTA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 23, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 23, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 23, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 20, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 20, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 20, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 27, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 22, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 22, 2026 | NWAP | NEW APPLICATION ENTERED | — |